Serum institute of India hopes to launch a COVID-19 vaccine every quarter
Serum institute of India aims to launch COVID-19 vaccine every quarter, CEO Adar Poonawalla said on Thursday, as reported by…
Serum institute of India aims to launch COVID-19 vaccine every quarter, CEO Adar Poonawalla said on Thursday, as reported by…
In the Lancet Journal the first full peer reviewed efficacy results got published for the COVID-19 vaccine AstraZeneca which was…
Oxford developed vaccine AstraZeneca accidentally reached 90% effectiveness. This happened when some of the trial participants got only half of…
“Oxford Vaccine may fit India better than the others being developed such as Moderna and Pfizer”, says Gagandeep Kang, a…